Abstract:Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by core symptoms that consist of social deficits and repetitive behaviors. Unfortunately, no effective medication is available thus far to target the core symptoms of ASD, since the pathogenesis remains largely unknown. To investigate the pathogenesis of the core symptoms in ASD, we constructed Shank1 P1812L-knock-in (KI) mice corresponding to a recurrent ASD-related mutation, SHANK1 P1806L, to achieve construct validity and face validity. Shank1 P1812L-KI heterozygous (HET) mice presented with social deficits and repetitive behaviors without the presence of confounding comorbidities. HET mice also exhibited downregulation of metabotropic glutamate receptor (mGluR1) and associated signals, along with structural abnormalities in the dendritic spines and postsynaptic densities. Combined with findings from Shank1 R882H-KI mice, our study confirms that mGluR1-mediated signaling dysfunction is a pivotal mechanism underlying the core symptoms of ASD. Interestingly, Shank1 P1812L-KI homozygous (HOM) mice manifested behavioral signs of impaired long-term memory rather than autistic-like core traits; thus, their phenotype was markedly different from that of Shank1 P1812L-KI HET mice. Correspondingly, at the molecular level, Shank1 P1812L-KI HOM displayed upregulation of AMPA receptor (GluA2)-related signals. The different patterns of protein changes in HOM and HET mice may explain the differences in behaviors. Our study emphasizes the universality of mGluR1-signaling hypofunction in the pathogenesis of the core symptoms in ASD, providing a potential target for therapeutic drugs. The precise correspondence between genotype and phenotype, as shown in HOM and HET mice, indicates the importance of reproducing disease-related genotypes in mouse models.

Glutaminase 1 Deficiency Confined in Forebrain Neurons Causes Autism Spectrum Disorder-Like Behaviors.

Microglial Glutaminase 1 Deficiency Mitigates Neuroinflammation Associated Depression.

Glutaminase C Overexpression in the Brain Induces Learning Deficits, Synaptic Dysfunctions, and Neuroinflammation in Mice.

Glutaminase 1 is essential for the differentiation, proliferation, and survival of human neural progenitor cells.

Brain glutathione and GABA+ levels in autistic children

Microglial over-pruning of synapses during development in autism-associated SCN2A-deficient mice and human cerebral organoids

Impaired calcium signaling in astrocytes modulates autism spectrum disorder-like behaviors in mice

Microglial glutaminase 1 mediates chronic restraint stress-induced depression-like behaviors and synaptic damages

GM1 Reduced the Symptoms of Autism Spectrum Disorder by Suppressing α-Syn Through Activating Autophagy

Impaired Amino Acid Transport at the Blood Brain Barrier Is a Cause of Autism Spectrum Disorder

Glutamate and GABA in autism spectrum disorder—a translational magnetic resonance spectroscopy study in man and rodent models

Loss of histone methyltransferase ASH1L in the developing mouse brain causes autistic-like behaviors

Genetics of glutamate and its receptors in autism spectrum disorder

SCGN deficiency is a risk factor for autism spectrum disorder

Microglial Tmem59 Deficiency Impairs Phagocytosis of Synapse and Leads to Autism-Like Behaviors in Mice

FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders

Elevated protein synthesis in microglia causes autism-like synaptic and behavioral aberrations

Downregulation of Mglur1-Mediated Signaling Underlying Autistic-Like Core Symptoms in Shank1 P1812L-knock-in Mice

Abnormal mGluR-mediated synaptic plasticity and autism-like behaviours in Gprasp2 mutant mice

Reduction of Glyoxalase 1 Expression Links Fetal Methylmercury Exposure to Autism Spectrum Disorder Pathogenesis

Axin2 coupled excessive Wnt-glycolysis signaling mediates social defect in autism spectrum disorders